New radiation technique aims to spare cervical cancer patients from gut woes
NCT ID NCT05197881
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This trial tests a new type of radiation therapy for cervical cancer that adjusts the beam daily based on the patient's anatomy. The goal is to reduce acute bowel side effects like diarrhea and urgency. About 125 patients with advanced cervical cancer will receive this treatment, and their reported side effects will be compared to historical rates from standard radiation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Daily adaptive external beam radiation therapy delivered via Varian Ethos system
What this could lead to
If successful, this approach could reduce acute gastrointestinal side effects like diarrhea and urgency during radiation for cervical cancer, making treatment more tolerable.
What could go wrong
This is an early-phase, single-arm study comparing results to historical data, not a randomized trial. The new technique may not significantly reduce side effects or could have unforeseen issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER BY FIGO STAGE 2018 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Fox Chase Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19111, United States
Contact Email: •••••@•••••
-
Moores Cancer Center at UC San Diego Health
RECRUITINGLa Jolla, California, 92037, United States
Contact Email: •••••@•••••
-
University of Alabama Birmingham
RECRUITINGBurmingham, Alabama, 35233, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
-
University of Arkansas Medical Sciences
RECRUITINGLittle Rock, Arkansas, 72205, United States
Contact Email: •••••@•••••
-
University of Texas Southwestern
RECRUITINGDallas, Texas, 75390, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••